000 | 01426 a2200409 4500 | ||
---|---|---|---|
005 | 20250511192101.0 | ||
264 | 0 | _c19920428 | |
008 | 199204s 0 0 eng d | ||
022 | _a0008-5472 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aAndrews, P A | |
245 | 0 | 0 |
_aMitochondrial defects in cis-diamminedichloroplatinum(II)-resistant human ovarian carcinoma cells. _h[electronic resource] |
260 |
_bCancer research _cApr 1992 |
||
300 |
_a1895-901 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 |
_aCarbonyl Cyanide m-Chlorophenyl Hydrazone _xpharmacology |
650 | 0 | 4 | _aCell Line |
650 | 0 | 4 |
_aCell Membrane _xdrug effects |
650 | 0 | 4 |
_aCisplatin _xpharmacology |
650 | 0 | 4 |
_aDrug Resistance _xphysiology |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFluorescent Dyes |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aKinetics |
650 | 0 | 4 |
_aMembrane Potentials _xdrug effects |
650 | 0 | 4 | _aMicroscopy, Electron |
650 | 0 | 4 | _aMicroscopy, Fluorescence |
650 | 0 | 4 |
_aMitochondria _xdrug effects |
650 | 0 | 4 |
_aNigericin _xpharmacology |
650 | 0 | 4 |
_aOnium Compounds _xmetabolism |
650 | 0 | 4 |
_aOrganophosphorus Compounds _xmetabolism |
650 | 0 | 4 | _aOvarian Neoplasms |
650 | 0 | 4 | _aRhodamine 123 |
650 | 0 | 4 |
_aRhodamines _xpharmacology |
700 | 1 | _aAlbright, K D | |
773 | 0 |
_tCancer research _gvol. 52 _gno. 7 _gp. 1895-901 |
|
999 |
_c1557603 _d1557603 |